# Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V
> **Rule** · Final rule. · Published 2022-11-09 · 87 FR 67548
## Document
- **Document number:** 2022-24157
- **Category:** scheduling
- **Type:** Rule
- **Action:** Final rule.
- **Citation:** 87 FR 67548
- **Publication date:** 2022-11-09
## Abstract

This final rule adopts, without change, an interim final rule with request for comments published in the Federal Register on June 1, 2022, placing ganaxolone (3[alpha]-hydroxy-3[beta]-methyl-5[alpha]- pregnan-20-one) and its salts in schedule V of the Controlled Substances Act. With the issuance of this final rule, the Drug Enforcement Administration maintains ganaxolone, including its salts, in schedule V of the Controlled Substances Act.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2022/11/09/2022-24157/schedules-of-controlled-substances-placement-of-ganaxolone-in-schedule-v)
---
*AI Analytics · CC0 1.0*